CVRx said M Health Fairview has completed its first Barostim implant, extending the rollout of the company’s heart-failure device therapy. The collaboration is

CVRx said M Health Fairview has completed its first Barostim implant, extending the rollout of the company’s heart-failure device therapy. The collaboration is aimed at widening patient access across the network as CVRx adds to recent implant milestones.